Vertex Pharmaceuticals is a global biotechnology company headquartered in Boston. Founded in 1989, the firm discovers, develops, and commercialises breakthrough treatments for serious diseases, with a particular focus on specialty markets. It is listed among the Fortune 500.
The company operates across the full drug-development pipeline, from scientific innovation and discovery through to commercialisation. Its work spans the biotechnology and pharmaceuticals industries, and it maintains a global operational footprint.
Vertex describes its culture as one of scientific excellence and collaboration, where scientists, researchers, and other professionals work together to translate laboratory discoveries into real-world treatments. The environment is characterised by an emphasis on rigorous inquiry and creativity.
